Carlsbad, CA, United States of America

Jie Fei Chang

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2009.


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jie Fei Chang: Innovator in Metabolic Modulation

Introduction

Jie Fei Chang is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of metabolic modulation through his innovative research and development of novel compounds.

Latest Patents

Chang holds a patent for "Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators." This invention relates to novel compounds, their prodrugs, and pharmaceutically acceptable salts. The pharmaceutical compositions containing these compounds are useful in treating various metabolic diseases. In particular, the invention focuses on the inhibition of the enzyme malonyl-coenzyme A decarboxylase (MCD). This inhibition is beneficial in the prophylaxis, management, and treatment of cardiovascular diseases, diabetes, acidosis, cancers, and obesity.

Career Highlights

Jie Fei Chang has been instrumental in advancing the understanding of metabolic diseases. His work has led to the development of innovative therapeutic strategies that target critical metabolic pathways. With 1 patent to his name, he continues to push the boundaries of scientific research.

Collaborations

Chang has collaborated with notable colleagues, including Yujin Huang and Lin Zhang. Their combined expertise has contributed to the success of their research endeavors.

Conclusion

Jie Fei Chang is a dedicated inventor whose work in metabolic modulation has the potential to impact the treatment of various diseases significantly. His innovative approach and collaboration with other experts highlight the importance of teamwork in scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…